Quell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3D9FZNY
via IFTTT